Cambrex announced today that it achieved multiple milestones in its effort to expand its active pharmaceutical ingredient (API) manufacturing. East Rutherford, New Jersey-based Cambrex said it completed the initial engineering studies for a new, large-scale API manufacturing plant in Charles City, Iowa. It also added further investment to support its Milan, Italy, site. The latest…
Cambrex expands peptide manufacturing capacity in Massachusetts
Cambrex announced today that its Snapdragon Chemistry company expanded its active pharmaceutical ingredient (API) facility in Waltham, Massachusetts. The expansion further supports the development and manufacturing of peptide therapies. East Rutherford, New Jersey-based Cambrex said its new GMP manufacturing suite increases the overall facility footprint by 20%. It also includes an ISO-7 cleanroom for preparative…